CorVel [CRVL] vs Marsh & McLennan [MMC] Detailed Stock Comparison

CorVel
NASDAQ
Loading...

Marsh & McLennan
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CorVel wins in 4 metrics, Marsh & McLennan wins in 15 metrics, with 0 ties. Marsh & McLennan appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | CorVel | Marsh & McLennan | Better |
---|---|---|---|
P/E Ratio (TTM) | 46.66 | 25.32 | Marsh & McLennan |
Price-to-Book Ratio | 13.49 | 6.58 | Marsh & McLennan |
Debt-to-Equity Ratio | 8.01 | 135.27 | CorVel |
PEG Ratio | 1.78 | 3.21 | CorVel |
EV/EBITDA | 28.06 | 16.34 | Marsh & McLennan |
Profit Margin (TTM) | 10.98% | 16.00% | Marsh & McLennan |
Operating Margin (TTM) | 15.03% | 26.91% | Marsh & McLennan |
EBITDA Margin (TTM) | 15.03% | 26.91% | Marsh & McLennan |
Return on Equity | 33.25% | 28.41% | CorVel |
Return on Assets (TTM) | 14.77% | 7.86% | CorVel |
Free Cash Flow (TTM) | $91.56M | $3.99B | Marsh & McLennan |
Dividend Yield | N/A | 1.51% | N/A |
1-Year Return | -11.65% | -5.72% | Marsh & McLennan |
Price-to-Sales Ratio (TTM) | 5.03 | 4.02 | Marsh & McLennan |
Enterprise Value | $4.45B | $123.84B | Marsh & McLennan |
EV/Revenue Ratio | 4.84 | 4.80 | Marsh & McLennan |
Gross Profit Margin (TTM) | 24.18% | 44.15% | Marsh & McLennan |
Revenue per Share (TTM) | $18 | $52 | Marsh & McLennan |
Earnings per Share (Diluted) | $1.93 | $8.33 | Marsh & McLennan |
Beta (Stock Volatility) | 0.95 | 0.78 | Marsh & McLennan |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CorVel vs Marsh & McLennan Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
CorVel | 2.86% | 5.09% | -0.61% | -19.09% | -12.75% | -15.07% |
Marsh & McLennan | -0.27% | 1.61% | 0.12% | -7.84% | -9.58% | -0.37% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
CorVel | -11.65% | 75.39% | 232.40% | 799.42% | 1,349.77% | 3,356.72% |
Marsh & McLennan | -5.72% | 26.87% | 84.69% | 288.97% | 778.76% | 680.68% |
Performance & Financial Health Analysis: CorVel vs Marsh & McLennan
Metric | CRVL | MMC |
---|---|---|
Market Information | ||
Market Cap | $4.62B | $103.70B |
Market Cap Category | Mid cap | Large cap |
10 Day Avg. Volume | 141,350 | 2,292,330 |
90 Day Avg. Volume | 159,667 | 2,608,213 |
Last Close | $92.64 | $210.55 |
52 Week Range | $85.13 - $128.61 | $196.27 - $248.00 |
% from 52W High | -27.97% | -15.10% |
All-Time High | $128.61 (Feb 03, 2025) | $248.00 (Mar 31, 2025) |
% from All-Time High | -27.97% | -15.10% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.11% | 0.12% |
Quarterly Earnings Growth | 0.26% | 0.08% |
Financial Health | ||
Profit Margin (TTM) | 0.11% | 0.16% |
Operating Margin (TTM) | 0.15% | 0.27% |
Return on Equity (TTM) | 0.33% | 0.28% |
Debt to Equity (MRQ) | 8.01 | 135.27 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $6.67 | $32.07 |
Cash per Share (MRQ) | $3.94 | $3.41 |
Operating Cash Flow (TTM) | $141.89M | $4.92B |
Levered Free Cash Flow (TTM) | $90.35M | $4.34B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 1.51% |
Last 12-Month Dividend | N/A | $3.24 |
Valuation & Enterprise Metrics Analysis: CorVel vs Marsh & McLennan
Metric | CRVL | MMC |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 46.66 | 25.32 |
Forward P/E | N/A | 22.37 |
PEG Ratio | 1.78 | 3.21 |
Price to Sales (TTM) | 5.03 | 4.02 |
Price to Book (MRQ) | 13.49 | 6.58 |
Market Capitalization | ||
Market Capitalization | $4.62B | $103.70B |
Enterprise Value | $4.45B | $123.84B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.84 | 4.80 |
Enterprise to EBITDA | 28.06 | 16.34 |
Risk & Other Metrics | ||
Beta | 0.95 | 0.78 |
Book Value per Share (MRQ) | $6.67 | $32.07 |
Financial Statements Comparison: CorVel vs Marsh & McLennan
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CRVL | MMC |
---|---|---|
Revenue/Sales | $234.71M | $7.06B |
Cost of Goods Sold | $177.95M | $3.85B |
Gross Profit | $56.76M | $3.21B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $35.28M | $2.01B |
EBITDA | $42.87M | $2.29B |
Pre-Tax Income | $35.28M | $1.83B |
Income Tax | $8.05M | $415.00M |
Net Income (Profit) | $27.24M | $1.41B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CRVL | MMC |
---|---|---|
Cash & Equivalents | $170.58M | $1.60B |
Total Current Assets | $386.69M | $22.46B |
Total Current Liabilities | $204.04M | $19.78B |
Long-Term Debt | $19.95M | $20.43B |
Total Shareholders Equity | $321.99M | $14.27B |
Retained Earnings | $903.09M | $25.88B |
Property, Plant & Equipment | $20.83M | $3.91B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CRVL | MMC |
---|---|---|
Operating Cash Flow | $28.56M | $1.27B |
Capital Expenditures | $-8.66M | N/A |
Free Cash Flow | $14.26M | $-677.00M |
Debt Repayment | N/A | $-505.00M |
Common Stock Repurchase | $-9.00M | $-300.00M |
Short Interest & Institutional Ownership Analysis
Metric | CRVL | MMC |
---|---|---|
Shares Short | 666,548 | 5.98M |
Short Ratio | 4.14 | 2.21 |
Short % of Float | 0.03% | 0.01% |
Average Daily Volume (10 Day) | 141,350 | 2,292,330 |
Average Daily Volume (90 Day) | 159,667 | 2,608,213 |
Shares Outstanding | 51.36M | 491.40M |
Float Shares | 28.73M | 490.71M |
% Held by Insiders | 0.44% | 0.00% |
% Held by Institutions | 0.54% | 0.93% |
Dividend Analysis & Yield Comparison: CorVel vs Marsh & McLennan
Metric | CRVL | MMC |
---|---|---|
Last 12-Month Dividend | N/A | $3.24 |
Last 12-Month Dividend Yield | N/A | 1.51% |
3-Year Avg Annual Dividend | N/A | $2.58 |
3-Year Avg Dividend Yield | N/A | 0.36% |
3-Year Total Dividends | N/A | $7.73 |
Ex-Dividend Date | N/A | Apr 03, 2025 |